Literature DB >> 33128105

Semaphorin 7A restricts serotonergic innervation and ensures recovery after spinal cord injury.

Kristina Loy1,2,3, Julie Fourneau1,2, Ning Meng1,2, Carmen Denecke1,2,3, Giuseppe Locatelli1,2, Florence M Bareyre4,5,6.   

Abstract

Descending serotonergic (5-HT) projections originating from the raphe nuclei form an important input to the spinal cord that control basic locomotion. The molecular signals that control this projection pattern are currently unknown. Here, we identify Semaphorin7A (Sema7A) as a critical cue that restricts serotonergic innervation in the spinal cord. Sema7A deficient mice show a marked increase in serotonergic fiber density in all layers of the spinal cord while the density of neurons expressing the corresponding 5-HTR2α receptor remains unchanged. These alterations appear to be successfully compensated as no obvious changes in rhythmic locomotion and skilled stepping are observed in adult mice. When the system is challenged with a spinal lesion, serotonergic innervation patterns in both Sema7A-deficient and -competent mice evolve over time with excessive innervation becoming most pronounced in the dorsal horn of Sema7A-deficient mice. These altered serotonergic innervation patterns correlate with diminished functional recovery that predominantly affects rhythmic locomotion. Our findings identify Sema7A as a critical regulator of serotonergic circuit formation in the injured spinal cord.

Entities:  

Keywords:  Locomotion; Patterning; Recovery; Semaphorin7A; Serotonin; Spinal cord injury

Mesh:

Substances:

Year:  2020        PMID: 33128105     DOI: 10.1007/s00018-020-03682-w

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  48 in total

Review 1.  Role of basal ganglia-brainstem pathways in the control of motor behaviors.

Authors:  K Takakusaki; K Saitoh; H Harada; M Kashiwayanagi
Journal:  Neurosci Res       Date:  2004-10       Impact factor: 3.304

Review 2.  Getting neural circuits into shape with semaphorins.

Authors:  R Jeroen Pasterkamp
Journal:  Nat Rev Neurosci       Date:  2012-08-16       Impact factor: 34.870

Review 3.  Semaphorin signaling: progress made and promises ahead.

Authors:  Yeping Zhou; Rou-Afza F Gunput; R Jeroen Pasterkamp
Journal:  Trends Biochem Sci       Date:  2008-04       Impact factor: 13.807

Review 4.  Axon guidance proteins in neurological disorders.

Authors:  Eljo Y Van Battum; Sara Brignani; R Jeroen Pasterkamp
Journal:  Lancet Neurol       Date:  2015-03-11       Impact factor: 44.182

Review 5.  Wiring the brain: the biology of neuronal guidance.

Authors:  Alain Chédotal; Linda J Richards
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-12       Impact factor: 10.005

6.  Pre- and post-natal ontogeny of serotonergic projections to the rat spinal cord.

Authors:  N Rajaofetra; F Sandillon; M Geffard; A Privat
Journal:  J Neurosci Res       Date:  1989-03       Impact factor: 4.164

7.  Semaphorin 7A promotes axon outgrowth through integrins and MAPKs.

Authors:  R Jeroen Pasterkamp; Jacques J Peschon; Melanie K Spriggs; Alex L Kolodkin
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

Review 8.  Modulation of the intrinsic properties of motoneurons by serotonin.

Authors:  Jean-François Perrier; Hanne Borger Rasmussen; Rasmus Kordt Christensen; Anders Victor Petersen
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Maturation of cortical circuits requires Semaphorin 7A.

Authors:  Ioana Carcea; Shekhar B Patil; Alfred J Robison; Roxana Mesias; Molly M Huntsman; Robert C Froemke; Joseph D Buxbaum; George W Huntley; Deanna L Benson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

Review 10.  The role of the serotonergic system in locomotor recovery after spinal cord injury.

Authors:  Mousumi Ghosh; Damien D Pearse
Journal:  Front Neural Circuits       Date:  2015-02-09       Impact factor: 3.492

View more
  1 in total

1.  Molecular and phenotypic characteristics of 15q24 microdeletion in pediatric patients with developmental disorders.

Authors:  Yuanyuan Zhang; Xiaoliang Liu; Haiming Gao; Wanting Cui; Bijun Zhang; Yanyan Zhao
Journal:  Mol Cytogenet       Date:  2021-12-18       Impact factor: 2.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.